144 related articles for article (PubMed ID: 10996199)
1. Bcl-2 and bax expression and chlorambucil-induced apoptosis in the T-cells and leukaemic B-cells of untreated B-cell chronic lymphocytic leukaemia patients.
Thomas A; Pepper C; Hoy T; Bentley P
Leuk Res; 2000 Oct; 24(10):813-21. PubMed ID: 10996199
[TBL] [Abstract][Full Text] [Related]
2. Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones.
Pepper C; Thomas A; Hoy T; Bentley P
Br J Haematol; 1999 Mar; 104(3):581-8. PubMed ID: 10086798
[TBL] [Abstract][Full Text] [Related]
3. Elevated Bcl-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukaemia and are correlated with in vivo chemoresistance.
Pepper C; Hoy T; Bentley P
Leuk Lymphoma; 1998 Jan; 28(3-4):355-61. PubMed ID: 9517506
[TBL] [Abstract][Full Text] [Related]
4. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A
Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352
[TBL] [Abstract][Full Text] [Related]
5. Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia.
Bosanquet AG; Sturm I; Wieder T; Essmann F; Bosanquet MI; Head DJ; Dörken B; Daniel PT
Leukemia; 2002 Jun; 16(6):1035-44. PubMed ID: 12040435
[TBL] [Abstract][Full Text] [Related]
6. Long-acting beta2-adrenergic formoterol and salmeterol induce the apoptosis of B-chronic lymphocytic leukaemia cells.
Mamani-Matsuda M; Moynet D; Molimard M; Ferry-Dumazet H; Marit G; Reiffers J; Mossalayi MD
Br J Haematol; 2004 Jan; 124(2):141-50. PubMed ID: 14687023
[TBL] [Abstract][Full Text] [Related]
7. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
Scamardella F; Maconi M; Albertazzi L; Gamberi B; Gugliotta L; Brini M
Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768
[TBL] [Abstract][Full Text] [Related]
8. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.
Kitada S; Andersen J; Akar S; Zapata JM; Takayama S; Krajewski S; Wang HG; Zhang X; Bullrich F; Croce CM; Rai K; Hines J; Reed JC
Blood; 1998 May; 91(9):3379-89. PubMed ID: 9558396
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
Morabito F; Filangeri M; Callea I; Sculli G; Callea V; Fracchiolla NS; Neri A; Brugiatelli M
Haematologica; 1997; 82(1):16-20. PubMed ID: 9107076
[TBL] [Abstract][Full Text] [Related]
10. Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia.
Saxena A; Viswanathan S; Moshynska O; Tandon P; Sankaran K; Sheridan DP
Am J Hematol; 2004 Jan; 75(1):22-33. PubMed ID: 14695629
[TBL] [Abstract][Full Text] [Related]
11. Chlorambucil in chronic lymphocytic leukemia: mechanism of action.
Begleiter A; Mowat M; Israels LG; Johnston JB
Leuk Lymphoma; 1996 Oct; 23(3-4):187-201. PubMed ID: 9031099
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.
Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW
Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 antisense oligonucleotides enhance the cytotoxicity of chlorambucil in B-cell chronic lymphocytic leukaemia cells.
Pepper C; Hooper K; Thomas A; Hoy T; Bentley P
Leuk Lymphoma; 2001 Jul; 42(3):491-8. PubMed ID: 11699414
[TBL] [Abstract][Full Text] [Related]
14. Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia.
Mainou-Fowler T; Prentice AG
Leuk Lymphoma; 1996 May; 21(5-6):369-77. PubMed ID: 9172801
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic drug resistance in B-cell chronic lymphocytic leukaemia--the role of Bcl-2 family dysregulation.
Pepper C; Thomas A; Hidalgo de Quintana J; Davies S; Hoy T; Bentley P
Leuk Res; 1999 Nov; 23(11):1007-14. PubMed ID: 10576505
[TBL] [Abstract][Full Text] [Related]
16. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
[TBL] [Abstract][Full Text] [Related]
17. Differential induction of apoptosis by fludarabine monophosphate in leukemic B and normal T cells in chronic lymphocytic leukemia.
Consoli U; El-Tounsi I; Sandoval A; Snell V; Kleine HD; Brown W; Robinson JR; DiRaimondo F; Plunkett W; Andreeff M
Blood; 1998 Mar; 91(5):1742-8. PubMed ID: 9473241
[TBL] [Abstract][Full Text] [Related]
18. Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia.
Pepper C; Thomas A; Hoy T; Fegan C; Bentley P
Br J Haematol; 2001 Jul; 114(1):70-7. PubMed ID: 11472347
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance.
Pepper C; Hoy T; Bentley DP
Br J Cancer; 1997; 76(7):935-8. PubMed ID: 9328155
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotides complementary to Bax transcripts reduce the susceptibility of B-cell chronic lymphocytic leukaemia cells to apoptosis in a bcl-2 independent manner.
Pepper C; Thomas A; Hoy T; Bentley P
Leuk Lymphoma; 2002 Oct; 43(10):2003-9. PubMed ID: 12481899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
